Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000306

Director sold 4,000 shares at an average $485.55 ($1,942,183)

  • Director acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BAUMGARTNER ROBERT V · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-23 Exercise or conversion : show line 1 in the form +4,000 $87.39 $349,560 13,612 D
2021-08-23 Sale : show line 2 in the form −299 $481.77 $144,050 13,313 D
2021-08-23 Sale : show line 3 in the form −601 $483.60 $290,643 12,712 D
2021-08-23 Sale : show line 4 in the form −600 $485.03 $291,015 12,112 D
2021-08-23 Sale : show line 5 in the form −1,600 $486.25 $778,004 10,512 D
2021-08-23 Sale : show line 6 in the form −800 $487.10 $389,682 9,712 D
2021-08-23 Sale : show line 7 in the form −100 $487.88 $48,788 9,612 D
Open-market sales · 4,000 sh · avg $485.55 · $1,942,183

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-23 Exercise or conversion : show line 8 in the form Stock Options (right to buy) −4,000 0 D
Loading xslF345X03/edgar.xml…